biosimilars

Viewpoint: Embracing biosimilars will drive down prices, increase access to drugs

The biosimilar category holds incredible promise, and the market for these products is on an upward trajectory. But it’s been ...
3-26-2019 gaining momentum on the road to accessible biosimilars

Viewpoint: We need to speed up biosimilar drug approval process

Generic versions of brand-name small-molecule drugs saved Americans more than $1 trillion between 1999 and 2010. Biosimilars now have the potential ...